Hepatitis C
Computer modeling reveals how surprisingly potent hepatitis C drug works
A study by researchers from Los Alamos National Laboratory and a multinational team reveals how daclatasvir, a direct-acting antiviral agent in development for the treatment of hepatitis C virus (HCV), targets one of its ...
Diseases, Conditions, Syndromes
Feb 18, 2013 |
4.8 / 5 (4) |
0
|
Chinese clinic suspected of infecting 95 patients
(AP)—Chinese state media say 95 people have been hospitalized after a private clinic gave them injections suspected to be contaminated with hepatitis C.
Diseases, Conditions, Syndromes
Feb 05, 2013 |
not rated yet |
0
Chronic hepatitis C: Interferon may be harmful in re-treatment
People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are ...
Diseases, Conditions, Syndromes
Jan 30, 2013 |
not rated yet |
0
Personalized plans to address barriers to HIV drug adherence boost chances of successful therapy
HIV patients who participated in an intervention that helped them identify barriers to taking their drugs properly and develop customized coping strategies took a significantly greater amount of their prescribed doses than ...
HIV & AIDS
Jan 29, 2013 |
5 / 5 (1) |
0
|
Predicting survival among those aging with HIV infection
(Medical Xpress)—A new collaborative study led by Yale, the VA Healthcare System, and the North American Cohort Collaboration supports the accuracy of an index used for predicting mortality as patients ...
HIV & AIDS
Jan 29, 2013 |
not rated yet |
0
2nd NY hospital warns of potential pen infection
(AP)—A second western New York hospital is notifying patients that they may have been exposed to HIV, hepatitis B or hepatitis C through the improper sharing of insulin pens.
Diseases, Conditions, Syndromes
Jan 24, 2013 |
not rated yet |
0
Binge drinking can dramatically amplify damage to the liver
Alcoholic liver disease (ALD) is characterized by a fatty liver, hepatitis, fibrosis, and cirrhosis. Binge drinking is on the rise worldwide, and is particularly common in the U.S. A review of studies addressing the effects ...
Addiction
Jan 22, 2013 |
not rated yet |
0
Generic HIV treatment strategy could save nearly $1 billion annually but may be less effective
Replacing the combination of brand-name, antiretroviral drugs currently recommended for control of HIV infection with soon-to-be-available generic medications could save the U.S. health care system almost $1 billion a year ...
HIV & AIDS
Jan 14, 2013 |
not rated yet |
0
Feds warned against risk seen in Buffalo VA
(AP)—Authorities are asking why a Buffalo veterans hospital may have reused insulin pens on many patients, causing an HIV scare, despite federal advice to the contrary.
Health
Jan 14, 2013 |
not rated yet |
0
Blood disorder cases tied to prescription painkiller abuse
(HealthDay)—Tennessee health officials report cases of a rare blood-clotting problem among people who injected the painkiller Opana ER (extended release) after crushing pills meant to be taken by mouth.
Medications
Jan 10, 2013 |
not rated yet |
0
|
Team discovers new gene that affects clearance of hepatitis C virus
(Medical Xpress)—Scientists have discovered a gene that interferes with the clearance of hepatitis C virus infection. They also identified an inherited variant within this gene, Interferon Lambda 4 (IFNL4), that predicts ...
Genetics
Jan 08, 2013 |
5 / 5 (1) |
0
|
Targeting hepatitis C treatment: The importance of interleukin (IL)-28
A metanalysis published in BioMed Central's open access journal BMC Medicine has confirmed that polymorphisms (SNP) in the gene coding for interleukin-28 (IL28B) influence natural hepatitis C viral (HCV) ...
Diseases, Conditions, Syndromes
Jan 07, 2013 |
not rated yet |
0
|
Interferon-free therapies for hep C virus look promising
(HealthDay)—For untreated patients with hepatitis C virus (HCV), treatment with an oral nucleotide inhibitor of HCV polymerase, sofosbuvir, plus ribavirin seems effective for genotypes 1, 2, and 3; and ...
Diseases, Conditions, Syndromes
Jan 03, 2013 |
not rated yet |
0
Sustained virological response linked with improved survival for patients with chronic HCV infection
Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with ...
Diseases, Conditions, Syndromes
Dec 25, 2012 |
5 / 5 (1) |
0
|
Hep C cases linked to NH hospital worker rise
(AP)—Five more people have been diagnosed with the same strain of hepatitis C a former traveling hospital worker is accused of spreading through tainted needles. The total is now 44 in four states.
Diseases, Conditions, Syndromes
Dec 21, 2012 |
not rated yet |
0
Hepatitis C is an infectious disease affecting primarily the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but chronic infection can lead to scarring of the liver and ultimately to cirrhosis, which is generally apparent after many years. In some cases, those with cirrhosis will go on to develop liver failure, liver cancer or life-threatening esophageal and gastric varices.
HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment and transfusions. An estimated 130–170 million people worldwide are infected with hepatitis C. The existence of hepatitis C (originally "non-A non-B hepatitis") was postulated in the 1970s and proven in 1989. It is not known to cause disease in other animals.
The virus persists in the liver in about 85% of those infected. This persistent infection can be treated with medication; peginterferon and ribavirin are the current standard therapy. Overall, between 50–80% of people treated are cured. Those who develop cirrhosis or liver cancer may require a liver transplant. Hepatitis C is the leading cause of liver transplantation though the virus usually recurs after transplantation. No vaccine against hepatitis C is currently available.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
Blame your parents for bunion woes
A novel study reports that white men and women of European descent inherit common foot disorders, such as bunions (hallux valgus) and lesser toe deformities, including hammer or claw toe. Findings from the Framingham Foot ...
Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak
Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics.
Treatment of sleep apnea improves glucose levels in prediabetes
Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in ...
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
Researchers identify a potential new risk for sleep apnea: Asthma
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
Study finds that sleep apnea and Alzheimer's are linked
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Returning genetic incidental findings without patient consent violates basic rights, experts say
Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...
Vicious cycle: Obesity sustained by changes in brain biochemistry
With obesity reaching epidemic levels in some parts of the world, scientists have only begun to understand why it is such a persistent condition. A study in the Journal of Biological Chemistry adds substantially to the st ...
